2,6-Dimethylanilino(oxo)acetic acid
Product Information
Molecular Formula
C10H11NO3
Molecular Weight
193.20
Description
2,6-Dimethylanilino(oxo)acetic acid is a state-of-the-art biomedical substance. This paramount entity exudes unparalleled prowess in suppressing a myriad of enzymes, thereby substantiating its prowess in quenching proliferative inflammatory cascades. Its efficacious potential spans across malignancies, cardiovascular irregularities, as well as perplexing autoimmune aberrations.
Synonyms
[(2,6-Dimethylphenyl)amino](oxo)acetic acid,[(2,6-Dimethylphenyl)carbamoyl]formic acid
IUPAC Name
2-(2,6-dimethylanilino)-2-oxoacetic acid
SMILES
CC1=C(C(=CC=C1)C)NC(=O)C(=O)O
InChI
InChI=1S/C10H11NO3/c1-6-4-3-5-7(2)8(6)11-9(12)10(13)14/h3-5H,1-2H3,(H,11,12)(H,13,14)
InChI Key
JFTAPSBIODPQJN-UHFFFAOYSA-N
Flash Point
Not applicable
Purity
95%
Computed Properties
XLogP3
1
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
2
Exact Mass
193.07389321 g/mol
Monoisotopic Mass
193.07389321 g/mol
Topological Polar Surface Area
66.4Ų
Heavy Atom Count
14
Formal Charge
0
Complexity
230
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-112430216-A | Preparation method of benzimidazole compound in pesticide and pesticide | 2020-11-23 |
| WO-2022049011-A1 | Imidazole-pyrazole derivatives with anti-bacterial properties | 2020-09-01 |
| WO-2022043486-A1 | Imidazole-pyrazole derivatives as antibacterials | 2020-08-31 |
| WO-2022047145-A1 | Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use | 2020-08-28 |
| WO-2021202688-A1 | Process for preparing a cot inhibitor compound | 2020-04-02 |
| JP-2021102593-A | A new compound that images tau | 2019-12-24 |
| WO-2021133752-A1 | Substituted heteroaryl compounds useful as t cell activators | 2019-12-23 |
| WO-2021084498-A1 | Fluorinated quinoline, quinoxaline and benzo[b][1,4]oxazine derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases | 2019-11-01 |
| WO-2021084500-A1 | Fluorinated quinoline and quinoxaline derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases | 2019-11-01 |
| WO-2021075476-A1 | Heterocyclic compound | 2019-10-18 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 21264963 | 2011-02-11 | Synthesis, crystal structures and magnetic properties of M(II)Cu(II) chains (M = Mn and Co) with sterically hindered alkyl-substituted phenyloxamate bridging ligands | Chemistry (Weinheim an der Bergstrasse, Germany) |
